HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isabelle Bernard-Pierrot Selected Research

Isabelle Bernard-Pierrot Research Topics

Disease

17Urinary Bladder Neoplasms (Bladder Cancer)
06/2023 - 01/2011
15Neoplasms (Cancer)
06/2023 - 08/2002
6Carcinoma (Carcinomatosis)
01/2023 - 01/2004
5Neoplasm Metastasis (Metastasis)
01/2023 - 08/2002
3Breast Neoplasms (Breast Cancer)
03/2014 - 09/2008
2Non-Muscle Invasive Bladder Neoplasms
06/2023 - 01/2023
2Carcinogenesis
01/2023 - 08/2002
1Ureteral Neoplasms (Ureteral Cancer)
01/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Sarcoma (Soft Tissue Sarcoma)
01/2021
1Tertiary Lymphoid Structures
01/2021
1Fibrosis (Cirrhosis)
12/2020
1Virus Diseases (Viral Diseases)
11/2018
1Adenocarcinoma
11/2013
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2013
1Ovarian Neoplasms (Ovarian Cancer)
01/2013
1Prostatic Neoplasms (Prostate Cancer)
05/2011
1Neuroblastoma
01/2004
1Glioma (Gliomas)
01/2004

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
06/2023 - 08/2002
4Phenobarbital (Luminal)FDA Link
01/2023 - 11/2014
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2017 - 08/2002
4pleiotrophin (HARP)IBA
05/2011 - 08/2002
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2022 - 12/2004
3Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2017
3ErbB Receptors (EGF Receptor)IBA
10/2015 - 10/2013
3Heparin (Liquaemin)FDA LinkGeneric
05/2011 - 08/2002
2LigandsIBA
06/2023 - 09/2017
2RNA (Ribonucleic Acid)IBA
01/2023 - 01/2011
2Phosphotransferases (Kinase)IBA
11/2018 - 09/2017
2Messenger RNA (mRNA)IBA
01/2018 - 09/2017
2Small Interfering RNA (siRNA)IBA
03/2014 - 11/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2023
1uridylyl-(3'-5')-guanosineIBA
06/2023
1CarcinogensIBA
01/2023
1Transcription Factors (Transcription Factor)IBA
01/2023
1VimentinIBA
01/2023
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2022
1Interleukin-7 (Interleukin 7)IBA
12/2021
1ProteomeIBA
01/2021
1InterferonsIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1mesoglycanIBA
12/2020
1c-Mer Tyrosine KinaseIBA
01/2019
1Insulin (Novolin)FDA Link
09/2017
1Growth Factor ReceptorsIBA
09/2017
1Carrier Proteins (Binding Protein)IBA
09/2017
1DecorinIBA
12/2013
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
10/2013
1AntibodiesIBA
01/2013
1Monoclonal AntibodiesIBA
01/2013
1IntegrinsIBA
01/2013
1Blocking AntibodiesIBA
01/2013
1Peptides (Polypeptides)IBA
05/2011
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2008
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
09/2008
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
12/2004
1Protein Isoforms (Isoforms)IBA
12/2004
1Insulin-Like Growth Factor II (Somatomedin A)IBA
12/2004
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2004
1MidkineIBA
01/2004
1N 30IBA
01/2004
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
08/2002
1Amino AcidsFDA Link
08/2002

Therapy/Procedure

7Therapeutics
01/2022 - 01/2013
2Radiotherapy
08/2022 - 12/2020
2Immunotherapy
01/2022 - 01/2021
1Drug Therapy (Chemotherapy)
01/2022
1Cystectomy
12/2020